Modified immunization vectors
US10370679B2 · kind B2 · utility
2Cited by
30References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 10, 2016 |
| Grant date | Aug 6, 2019 |
| Priority date | — |
| Expiry date | Oct 10, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to recombinant vectors and methods for using the same. In certain embodiments, the recombinant vectors are immunogenic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.